Gemcitabine Hydrochloride
3 NDCs across 3 manufacturers|3 Generic,0 Brand
Gemcitabine Hydrochloride is used to treat breast neoplasms, non-small-cell lung carcinoma, pancreatic ductal carcinoma and ovarian neoplasms, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 15, 1996, and the first generic was approved Nov 15, 2010.
Gemcitabine Hydrochloride is available as 3 NDCs from 3 manufacturers (3 generic, 0 brand), with NADAC prices from $20.00 to $20.00 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
3G / 0B
Manufacturers
3
competing in market
Price Spread
$20.00 – $20.00
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
NorthStar Rx LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nucleoside Metabolic Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing GEMCITABINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GEMCITABINE HCL 1 GRAM VIAL | $19.9960 per EA | — |
GEMCITABINE HCL 1 GRAM VIAL | $19.9960 per EA | — |
GEMCITABINE HCL 1 GRAM VIAL | $19.9960 per EA | — |
Frequently Asked Questions
What is Gemcitabine Hydrochloride used to treat?
Gemcitabine Hydrochloride is used to treat breast neoplasms, non-small-cell lung carcinoma, pancreatic ductal carcinoma and ovarian neoplasms, per the National Library of Medicine's MED-RT classification.
When did Gemcitabine Hydrochloride become available as a generic?
FDA approved the first generic Gemcitabine Hydrochloride (ANDA) on Nov 15, 2010.
How many Gemcitabine Hydrochloride products are on the market?
The Gemcitabine Hydrochloride drug market contains 3 NDCs from 3 manufacturers — 3 generic and 0 brand products.
What is the price range for Gemcitabine Hydrochloride?
NADAC reference prices for Gemcitabine Hydrochloride range from $19.9960 to $19.9960 per EA.
Which manufacturers make Gemcitabine Hydrochloride?
3 manufacturers list Gemcitabine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are NorthStar Rx LLC (1), Sagent Pharmaceuticals (1), Meitheal Pharmaceuticals Inc. (1).